The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death

Kawauchi, D; Takahashi, M; Satomi, K; Yamamuro, S; Kobayashi, T; Uchida, E; Honda-Kitahara, M; Narita, Y; Iwadate, Y; Ichimura, K; Tomiyama, A

Tomiyama, A (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.

CANCER SCIENCE, 2021; 112 (6): 2442

Abstract

Glioblastoma (GBM) is the most common, but extremely malignant, brain tumor; thus, the development of novel therapeutic strategies for GBMs is imperat......

Full Text Link